Management of Elevated Creatine Kinase in Hashimoto's Thyroiditis
For patients with Hashimoto's thyroiditis and elevated creatine kinase (CK) levels, thyroid hormone replacement therapy with levothyroxine is the primary treatment, which typically leads to normalization of CK levels and resolution of any associated muscle symptoms.
Diagnostic Evaluation
Complete a thorough rheumatologic and neurologic history and examination, including muscle strength assessment, to differentiate hypothyroid myopathy from other causes of elevated CK 1
Evaluate for muscle weakness, which is more typical of myositis than pain alone 1
Order comprehensive laboratory testing:
Additional testing if diagnosis is uncertain:
Treatment Approach
Primary Management
Management Based on Symptom Severity
Mild muscle symptoms with elevated CK:
Moderate muscle weakness with elevated CK:
Severe muscle weakness with markedly elevated CK:
Monitoring and Follow-up
- Monitor thyroid function (TSH, free T4) regularly until stable, then every 6-12 months 2
- Follow CK levels until normalization 1
- Reassess muscle strength and symptoms at follow-up visits 1
- Expect improvement in muscle symptoms and normalization of CK with adequate thyroid hormone replacement 3, 4
Important Clinical Considerations
- Hypothyroid myopathy can present with strikingly elevated CK levels (>20,000 IU/L) that mimic inflammatory myopathies, making thyroid function testing essential in all patients with elevated CK 5
- Muscle weakness and elevated CK may be the predominant or initial presentation of hypothyroidism, even when other thyroid symptoms are minimal 3, 5
- Rapid correction of thyroid hormone levels (as in treatment of hyperthyroidism) can paradoxically cause relative hypothyroidism and myopathy with elevated CK 6
- If CK remains elevated despite adequate thyroid hormone replacement, consider additional muscle biopsy and biochemical evaluation for other myopathies 7
- Hashimoto's thyroiditis may coexist with other autoimmune conditions that can cause myopathy, such as systemic lupus erythematosus, requiring careful differential diagnosis 4